Microport Cardioflow Medtech Corp (2160)

Currency in HKD
1.28
0.00(0.00%)
Closed·
2160 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
1.281.28
52 wk Range
0.936.80
Key Statistics
Bid/Ask
1.28 / 1.32
Prev. Close
1.28
Open
1.28
Day's Range
1.28-1.28
52 wk Range
0.93-6.8
Volume
-
Average Volume (3m)
1.36M
1-Year Change
-80.7519%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
2160 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
6.92
Upside
+440.45%
Members' Sentiments
Bearish
Bullish
ProTips
Trading at a low Price / Book multiple
Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Sell
Technical Indicators
Sell
Moving Averages
Sell

Analyst Ratings

2 Buy
0 Hold
0 Sell
Ratings:
2 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 6.92
(+440.45% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
Citi
Buy6.20+384.38%8.00MaintainApr 13, 2026

Earnings

Latest Release
Mar 30, 2026
EPS / Forecast
-- / --
Revenue / Forecast
84.93M / --
EPS Revisions
Last 90 days

2160 Income Statement

Compare 2160 to Peers and Sector

Metrics to compare
2160
Peers
Sector
Relationship
P/E Ratio
−11.0x−2.1x−0.3x
PEG Ratio
0.070.100.00
Price/Book
0.8x1.8x2.6x
Price / LTM Sales
3.6x4.5x3.0x
Upside (Analyst Target)
-124.1%62.1%
Fair Value Upside
Unlock0.9%8.1%Unlock

MicroPort CardioFlow Medtech Corporation, together with its subsidiaries, researches, develops, manufactures, and sells medical devices for the treatment of structural heart disease and cardiac rhythm management in China, Europe, the Middle East, Africa, Asia, North America, and internationally. The company offers VitaFlow, a transcatheter aortic valve system; VitaFlow Liberty, a transcatheter aortic valve retrievable and controllable bend delivery system; Alwide, a plus valve balloon dilation catheter; AccuSniper, a double-layer balloon dilation catheter, Angelguide, an advanced pre-shaped ultra-hard guidewire; and AnchorMan, a left atrial appendage occlusion and guidance system. It also provides various active, mitral, and tricuspid valve products; left atrial appendage closure products; surgical accessories; low and high-voltage CRM products; leads and accessories; patient monitoring products; and arrhythmia diagnostic devices. In addition, the company offers clinical solutions, including aortic stenosis and atrial fibrillation-related stroke prevention. Further, it is involved in the manufacturing of raw materials for medical devices treating valvular heart diseases; and properties management. The company was founded in 2009 and is headquartered in Shanghai, China.

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
772.63K0.06%988.96K
Other Institutional Investors
908.78M71.37%1.16B
Public Companies & Retail Investors
363.76M28.57%465.61M
Total
1.27B100.00%1.63B

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
MicroPort Scientific Corporation44.45%565,948,290724,414
Hillhouse Fund IV, L.P.8.46%107,700,363137,856

FAQ

What Is the Microport Cardioflow Medtech (2160) Stock Price Today?

The Microport Cardioflow Medtech stock price today is 1.28 HKD.

What Stock Exchange Does Microport Cardioflow Medtech Trade On?

Microport Cardioflow Medtech is listed and trades on the Hong Kong Stock Exchange.

What Is the Stock Symbol for Microport Cardioflow Medtech?

The stock symbol for Microport Cardioflow Medtech is "2160."

What Is the Microport Cardioflow Medtech Market Cap?

As of today, Microport Cardioflow Medtech market cap is 1.63B HKD.

What Is Microport Cardioflow Medtech's Earnings Per Share (TTM)?

The Microport Cardioflow Medtech EPS (TTM) is -0.04.

From a Technical Analysis Perspective, Is 2160 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.

How Many Times Has Microport Cardioflow Medtech Stock Split?

Microport Cardioflow Medtech has split 1 times.

How Many Employees Does Microport Cardioflow Medtech Have?

Microport Cardioflow Medtech has 1415 employees.

What is the current trading status of Microport Cardioflow Medtech (2160)?

As of Oct 13, 2026, Microport Cardioflow Medtech (2160) is trading at a price of 1.28 HKD, with a previous close of 1.28 HKD. The stock has fluctuated within a day range of 1.28 HKD to 1.28 HKD, while its 52-week range spans from 0.93 HKD to 6.80 HKD.

What Is Microport Cardioflow Medtech (2160) Price Target According to Analysts?

The average 12-month price target for Microport Cardioflow Medtech is 6.92 HKD, with a high estimate of 7.58410503 HKD and a low estimate of 6.25131872 HKD. 2 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +440.45% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2026 - Fusion Media Limited. All Rights Reserved.